Suchergebnisse - "Mahmood, Adnan"

PubPharm (43)

1

A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19

enthalten in: bioRxiv.org | 2024

von Sivapalasingam, S. | Lederer, D. | Bhore, R. | +37

2

MESMERIC : Machine Learning-Based Trust Management Mechanism for the Internet of Vehicles

enthalten in: Sensors (Basel, Switzerland) | 2024

von Wang, Y. | Mahmood, A. | Sabri, M. | +2

3

Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019 : A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial

enthalten in: Open forum infectious diseases | 2023

von Somersan-Karakaya, S. | Mylonakis, E. | Mou, J. | +14

4

Dynamic Correlation Adjacency-Matrix-Based Graph Neural Networks for Traffic Flow Prediction

enthalten in: Sensors (Basel, Switzerland) | 2023

von Gu, J. | Jia, Z. | Cai, T. | +2

5

Towards a Machine Learning Driven Trust Management Heuristic for the Internet of Vehicles

enthalten in: Sensors (Basel, Switzerland) | 2023

von Siddiqui, S. | Mahmood, A. | Sheng, Q. | +2

6

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough

enthalten in: Lung | 2023

von McGarvey, L. | Smith, J. | Morice, A. | +12

7

Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19

enthalten in: The Journal of infectious diseases | 2022

von Somersan-Karakaya, S. | Mylonakis, E. | Menon, V. | +31

8

Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing Antibodies

enthalten in: mBio | 2022

von Hooper, A. | Somersan-Karakaya, S. | McCarthy, S. | +12

9

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough

enthalten in: Lung | 2022

von McGarvey, L. | Smith, J. | Morice, A. | +12

10

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough

enthalten in: Lung | 2022

von McGarvey, L. | Smith, J. | Morice, A. | +12

1
2
3
4
5
Nächster »
[5]